BMS Mulls CAR-T Manufacturing in Japan, Definitive Plans Expected by Year-End

Lynelle Hoch, Senior Vice President, Global Cell Therapy Franchise, Bristol Myers Squibb Bristol Myers Squibb is considering ramping up its supply capacity of CAR-T cell therapies for Japan by building out a manufacturing regime in the country, whether it be...read more